AR and prostate cancer: Ginsenoside Rb1 inhibited vascular calcification as a selective androgen receptor modulator as evidenced by exhibiting inhibitory effects on vascular smooth muscle cells (VSMCs) calcification through androgen receptor-mediated Gas6 transactivation and antagonistic effects in prostate cancer cells [32].